These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28303667)

  • 1. Exercise-induced saphenous vein graft spasm prevented by stenting.
    Boliek WG; Kereiakes DJ; Chugh A
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):937-944. PubMed ID: 28303667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
    Taggart DP; Ben Gal Y; Lees B; Patel N; Webb C; Rehman SM; Desouza A; Yadav R; De Robertis F; Dalby M; Banning A; Channon KM; Di Mario C; Orion E
    Ann Thorac Surg; 2015 Jun; 99(6):2039-45. PubMed ID: 25886810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent implantation in saphenous vein grafts.
    Lozano I; Avanzas P; Rondan J
    Am J Cardiol; 2009 Apr; 103(7):1042-3. PubMed ID: 19327440
    [No Abstract]   [Full Text] [Related]  

  • 6. Hinge motion and excessive negative remodeling as a cause of early saphenous vein graft failure.
    Kume T; Okura H; Fukuhara K; Koyama T; Nezuo S; Neishi Y; Hayashida A; Kawamoto T; Tanemoto K; Yoshida K
    JACC Cardiovasc Interv; 2013 Mar; 6(3):e15-6. PubMed ID: 23517849
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous intervention of a thrombotic-occluded saphenous vein graft successfully treated using the undersized stent approach to prevent distal embolization.
    Maluenda G; Alfonso F; Pichard AD
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):65-9. PubMed ID: 21328690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
    Pokala NR; Menon RV; Patel SM; Christopoulos G; Christakopoulos GE; Kotsia AP; Rangan BV; Roesle M; Abdullah S; Grodin J; Kumbhani DJ; Hastings J; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):34-40. PubMed ID: 26033073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombus removal prior to recanalization in vein graft occlusion intervention.
    Fung RC; Jim MH
    Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):121-123. PubMed ID: 29719982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patency of the saphenous vein conduit anastomosed to the aortic dacron graft.
    Kara I; Koksal C; Boyacioglu K; Ay Y; Yanartas M; Metin Esen A
    J Cardiovasc Surg (Torino); 2013 Oct; 54(5):647-52. PubMed ID: 24002395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and clinical results of everolimus-eluting stent utilization in saphenous vein graft lesions (ARES).
    Jim MH; Wong KL; Yiu KH
    Int J Cardiol; 2015 Apr; 184():433-435. PubMed ID: 25755061
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up.
    Ho PC; Lee AC; Fortuna R
    J Invasive Cardiol; 2012 Oct; 24(10):516-20. PubMed ID: 23043035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staged stenting of a long aneurysm of a saphenous vein coronary artery bypass graft.
    Jamshidi P; Resink T; Erne P
    J Invasive Cardiol; 2008 Jan; 20(1):E1-5. PubMed ID: 18174622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current percutaneous treatment strategies for saphenous vein graft disease.
    Marmagkiolis K; Grines C; Bilodeau L
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):406-13. PubMed ID: 22777812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-intervention of a fibrotic lesion in a saphenous vein graft: Insights into procedural characteristics using the right transradial approach.
    Vogiatzi G; Toutouzas K; Synetos A; Latsios G; Tousoulis D
    Hellenic J Cardiol; 2017; 58(4):297-299. PubMed ID: 28286169
    [No Abstract]   [Full Text] [Related]  

  • 18. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.
    Harskamp RE; Lopes RD; Baisden CE; de Winter RJ; Alexander JH
    Ann Surg; 2013 May; 257(5):824-33. PubMed ID: 23574989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
    Agostoni P; Vermeersch P; Semeraro O; Verheye S; Van Langenhove G; Van den Heuvel P; Convens C; Van den Branden F; Bruining N
    Am J Cardiol; 2007 Jul; 100(1):52-8. PubMed ID: 17599440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.